MSH|^~\&|MIC|ARH|||201910241015||ORU^R01|4088313|D|2.3|||AL|NE
PID|1||AB00008279|AB8185|LABTESTCOLLIE^LUMED^^^^||20050504|F|||234 MAIN ST^^ABBOTSFORD^BC^V0X 1T0||(604)851-4700|||||AB000559/19|9874974606
PV1|1|O|AB.ZPS^^||||LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5|||||||||||REF||HP|||||||||||||||||||ARH||REG|||201910151034||||||
OBR|1|34460^MIC|00026489^19:U0000306R^MIC^19:U306^34460|500.1000^U^Urine Culture^^^630-4||201910240903|201910240810|||||||201910240903|Urine^^^Midstream urine|LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5||||||||MB|F||^^^^^R|LABTESTG2^Labtest^Generic^Doc2^^^^^DOC^V2H 3H5~LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5|
OBX|1|ST|500.1000^U^Urine Culture^^^630-4^S:NG24|1|No growth after 24 hours incubation.||||||F|||201910241015|SMH^Surrey Memorial Hospital^(604)588-3324^L

MSH|^~\&|MIC|ARH|||201910241034||ORU^R01|4088348|D|2.3|||AL|NE
PID|1||AB00008279|AB8185|LABTESTCOLLIE^LUMED^^^^||20050504|F|||234 MAIN ST^^ABBOTSFORD^BC^V0X 1T0||(604)851-4700|||||AB000559/19|9874974606
PV1|1|O|AB.ZPS^^||||LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5|||||||||||REF||HP|||||||||||||||||||ARH||REG|||201910151034||||||
OBR|1|34464^MIC|00026492^19:B0000326R^MIC^19:B326^34464|100.5005^BC^Blood culture^^^600-7||201910240913|201910190700|||||||201910190710|Blood^^^Peripheral|LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5||||||||MB|I||^^^^^R|LABTESTG2^Labtest^Generic^Doc2^^^^^DOC^V2H 3H5~LABTESTG1^Labtest^Generic^Doc1^^^^99009^DOC^V2V 2J5|
OBX|1|CE|100.5010^BCT^Blood culture^^6463-4^600-7^O:ECOL|1.1|ECOL^Escherichia coli||||||P|||201910241034|SMH^Surrey Memorial Hospital^(604)588-3324^L
OBX|2|ST|100.5010^BCT^Blood culture^^6463-4^600-7^P:BCSET|1.1|Sets positive:||||||P|||201910241034|SMH^Surrey Memorial Hospital^(604)588-3324^L
OBX|3|ST|100.5010^BCT^Blood culture^^6463-4^600-7^R:1/2|1.1|One out of two.||||||P|||201910241034|SMH^Surrey Memorial Hospital^(604)588-3324^L
OBX|4|ST|100.5010^BCT^Blood culture^^6463-4^600-7^P:BCTIME|1.1|   Isolated after:||||||P|||201910241034|SMH^Surrey Memorial Hospital^(604)588-3324^L
OBX|5|ST|100.5010^BCT^Blood culture^^6463-4^600-7^R:1D|1.1|One day of incubation.||||||P|||201910241034|SMH^Surrey Memorial Hospital^(604)588-3324^L
OBX|6|ST|100.5010^BCT^Blood culture^^6463-4^600-7^P:ORGIDSECOM|1.1|||||||P|||201910241034|SMH^Surrey Memorial Hospital^(604)588-3324^L
OBX|7|ST|100.5010^BCT^Blood culture^^6463-4^600-7^R:SUW|1.1|Susceptibilities underway.||||||P|||201910241034|SMH^Surrey Memorial Hospital^(604)588-3324^L
OBX|8|ST|100.5010^BCT^Blood culture^^6463-4^600-7|1.1|||||||P|||201910241034|SMH^Surrey Memorial Hospital^(604)588-3324^L
NTE|1||**CRITICAL VALUE**
NTE|2||Nursing unit/office to notify physician immediately.
NTE|3||Phoned to nursing unit/office: Dr.Labtest
NTE|4||Date: 24/10/19 Time: 1031
NTE|5||
NTE|6||Preliminary susceptibility testing suggests this organism
NTE|7||may be resistant to cephalosporins (including ceftriaxone)
NTE|8||and piperacillin/tazobactam. Meropenem (or Ertapenem if
NTE|9||outpatient) is recommended for empiric treatment pending
NTE|10||final susceptibility results.

MSH|^~\&|MIC|ARH|||201910241027||ORU^R01|4088337|D|2.3|||AL|NE
PID|1||AB00008279|AB8185|LABTESTCOLLIE^LUMED^||20050504|F||||||||||AB000559/19|9874974606
OBR|1|34459^MIC|00026488^19:M0000344R^MIC^19:M344^34459|400.1000^S^Sputum culture and gram stain^^^6460-0||201910240901|201910232230|||||||201910232300|Sputum^^^Expectorated|||||||||MB|F||||
NTE|1||Testing for LUMED
OBX|1|ST|100.0300^GSS^Gram stain^^664-3^664-3^P:GRAMS|1|||||||F|||201910241026
OBX|2|ST|100.0300^GSS^Gram stain^^664-3^664-3^R:4 P|1|4+ Polymorphonuclear cells||||||F|||201910241026
OBX|3|ST|100.0300^GSS^Gram stain^^664-3^664-3^R:4 GPC|1|4+ Gram positive cocci||||||F|||201910241026
OBX|4|ST|100.0300^GSS^Gram stain^^664-3^664-3^R:3 GNB|1|3+ Gram negative bacilli||||||F|||201910241026
OBX|5|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^P:MIXSC|2|||||||F|||201910241026
OBX|6|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^R:1 RF|2|1+ Respiratory flora||||||F|||201910241026
OBX|7|CE|400.2000^SC^Sputum culture^^6463-4^6460-0^O:SAUR|2.1|SAUR^Staphylococcus aureus||||||F|||201910241026
OBX|8|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^P:AMT|2.1|||||||F|||201910241026
OBX|9|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^R:4|2.1|4+||||||F|||201910241026
OBX|10|CE|400.2000^SC^Sputum culture^^6463-4^6460-0^O:SGC|2.2|SGC^Group C streptococcus||||||F|||201910241026
OBX|11|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^P:AMT|2.2|||||||F|||201910241026
OBX|12|ST|400.2000^SC^Sputum culture^^6463-4^6460-0^R:4|2.2|4+||||||F|||201910241026
OBX|13|CE|400.2000^SC^Sputum culture^^6463-4^6460-0^O:KPNE|2.3|KPNE^Klebsiella pneumoniae||||||F|||201910241026
OBX|14|ST|400.2000^SC^Sputum culture^^6463-4^6460-0|2.3|||||||F|||201910241026
NTE|1||{Group C streptococcus}
NTE|2||Beta hemolytic group C Streptococci are universally
NTE|3||susceptible to the penicillins and cephalosporins, and
NTE|4||resistant to ciprofloxacin and
NTE|5||trimethoprim/sulfamethoxazole.  Alternate antibiotics are
NTE|6||clindamycin (80-90% susceptible) and erythromycin (70-80%
NTE|7||susceptible).
OBR|2||00026488^19:M0000344R^MIC^19:M344^34459|913.2500^P580^Vitek P580 Sensitivity^^^29576-6||201910240901|201910232230|||||||201910232300|Sputum^^^Expectorated|||||||||MB|C|6463-4^2.1|||34459^MIC
OBX|1|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||F|||201910241026
OBX|2|ST|101.100^CF^Cephalexin^^149-5^149-5|||||S|||F|||201910241026
OBX|3|ST|200.000^AUG^Amoxicillin/Clavulanate^^20-8^20-8|||||S|||F|||201910241026
OBX|4|ST|200.600^OX^Cloxacillin^^197-4^197-4|||||S|||F|||201910241026
OBX|5|ST|400.200^E^Erythromycin^^233-7^233-7|||||S|||F|||201910241026
OBX|6|ST|400.300^CD^Clindamycin^^193-3^193-3|||||R|||F|||201910241026
OBX|7|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201910241026
OBX|8|ST|800.000^VA^Vancomycin^^524-9^524-9|||||S|||F|||201910241026
OBR|3||00026488^19:M0000344R^MIC^19:M344^34459|903.3100^N213^Vitek N213 Sensitivity^^^29576-6||201910240901|201910232230|||||||201910232300|Sputum^^^Expectorated|||||||||MB|C|6463-4^2.3|||34459^MIC
OBX|1|ST|100.400^CFT^Cefotaxime^^108-1^108-1|||||S|||F|||201910241026
OBX|2|ST|100.900^CFM^Cefixime^^80-2^80-2|||||S|||F|||201910241026
OBX|3|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||I|||F|||201910241026
OBX|4|ST|101.100^CF^Cephalexin^^149-5^149-5|||||I|||F|||201910241026
OBX|5|ST|200.100^AM^Ampicillin^^28-1^28-1|||||R|||F|||201910241026
OBX|6|ST|300.000^AK^Amikacin^^12-5^12-5|||||S|||F|||201910241026
OBX|7|ST|300.100^TO^Tobramycin^^508-2^508-2|||||I|||F|||201910241026
OBX|8|ST|300.200^GM^Gentamicin^^267-5^267-5|||||R|||F|||201910241026
OBX|9|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201910241026

MSH|^~\&|MIC|RCH|||201910290952||ORU^R01|4092590|D|2.3|||AL|NE
PID|1||RC00007420|RC7220|LABTEST^XRCCARDIAC^ONE||19450822|M||||||||||RC001069/18|9875418595
OBR|1|34610^MIC|00026596^19:U0000310R^MIC^19:U310^34610|500.1000^U^Urine Culture^^^630-4||201910290952|201910290951|||||||201910290951|Urine^^^Midstream urine|||||||||MB|F||||
OBX|1|ST|500.1000^U^Urine Culture^^^630-4^S:NG|1|No growth||||||F|||201910290952

MSH|^~\&|MIC|SMH|||201910310858||ORU^R01|4094594|D|2.3|||AL|NE
PID|1||SM00044960|SM44763|MICTEST^BABY^NOBDAY|||M||||||||||SM000973/19|
OBR|1|34723^MIC|00026669^19:W0000570R^MIC^19:W570^34723|205.2000^FLE^Eye fluid culture and gram^^^636-1||201910310843|20191031UNK|||||||201910310842|Corneal scrapings^^^Right|||||||||MB|F||||
OBX|1|ST|100.0500^GSF^Gram stain^^664-3^664-3^S:TNP|1|Test not performed||||||F|||201910310858
OBX|2|CE|205.1000^FLEC^Eye Fluid^^6463-4^636-1^O:MRSA|2.1|MRSA^Staphylococcus aureus-MRSA||||||F|||201910310858
OBX|3|ST|205.1000^FLEC^Eye Fluid^^6463-4^636-1^P:AMT|2.1|||||||F|||201910310858
OBX|4|ST|205.1000^FLEC^Eye Fluid^^6463-4^636-1^R:1|2.1|1+||||||F|||201910310858
OBX|5|ST|205.1000^FLEC^Eye Fluid^^6463-4^636-1|2.1|||||||F|||201910310858
NTE|1||A copy of the result has been sent to Infection Control.
OBR|2||00026669^19:W0000570R^MIC^19:W570^34723|913.2500^P580^Vitek P580 Sensitivity^^^29576-6||201910310843|20191031UNK|||||||201910310842|Corneal scrapings^^^Right|||||||||MB|F|6463-4^2.1|||34723^MIC
OBX|1|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||R|||F|||201910310858
NTE|1||This is a test note added to an antibiogram result to
NTE|2||validate how it is imported into Lumed.
OBX|2|ST|101.100^CF^Cephalexin^^149-5^149-5|||||R|||F|||201910310858
OBX|3|ST|200.000^AUG^Amoxicillin/Clavulanate^^20-8^20-8|||||R|||F|||201910310858
OBX|4|ST|200.600^OX^Cloxacillin^^197-4^197-4|||||R|||F|||201910310858
OBX|5|ST|400.200^E^Erythromycin^^233-7^233-7|||||R|||F|||201910310858
OBX|6|ST|400.300^CD^Clindamycin^^193-3^193-3|||||R|||F|||201910310858
OBX|7|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201910310858
OBX|8|ST|800.000^VA^Vancomycin^^524-9^524-9|||||S|||F|||201910310858

MSH|^~\&|MIC|ARH|||201910291758||ORU^R01|4093277|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34603^MIC|00026590^19:MT0000181R^MIC^19:MT181^34603|700.1950^CDT^C. difficile Assay^^^XXX-2144||201910290807|201910290803|||||||201910290803|Stool^^^|||||||||MB|F||||
OBX|1|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|Patients positive for the C. difficile toxin B gene should||||||F|||201910291758
OBX|2|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|not have a test of cure as the test may remain positive for||||||F|||201910291758
OBX|3|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|months after symptom resolution.||||||F|||201910291758
OBX|4|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|Approximately 25% of adequately treated patients will have a||||||F|||201910291758
OBX|5|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|relapse of C. difficile disease. Repeat C. difficile testing||||||F|||201910291758
OBX|6|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|is not helpful.||||||F|||201910291758
OBX|7|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|||||||F|||201910291758
OBX|8|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|A copy of these results has been sent to Infection||||||F|||201910291758
OBX|9|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|Prevention and Control.||||||F|||201910291758
OBX|10|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|||||||F|||201910291758
OBX|11|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|For mild or first recurrent Clostridium difficile associated||||||F|||201910291758
OBX|12|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|diarrhea in adults, treatment with oral vancomycin is now||||||F|||201910291758
OBX|13|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|considered more effective than metronidazole.  Consult||||||F|||201910291758
OBX|14|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|Infectious Disease Society of America (IDSA) 2017||||||F|||201910291758
OBX|15|ST|700.2060^CDTPCR R^C. difficile toxin B gene^^74822-8^74822-8|1|C.difficile guideline or UpToDate.||||||F|||201910291758

MSH|^~\&|MIC|ARH|||201910291845||ORU^R01|4093278|D|2.3|||AL|NE
PID|1||AB00008278|AB8184|LABTESTBEAGLE^LUMED^||19700302|F||||||||||AB000558/19|9874974645
OBR|1|34604^MIC|00026590^19:X0000060R^MIC^19:X60^34604|800.5700^MDRO^Multiresistant organism screen^^^XBC3337-4||201910290807|201910290803|||||||201910290803|Sputum^^^Expectorated|||||||||MB|F||||
OBX|1|CE|800.5800^MDRO R^Multiresistant organism screen^^11502-2A^XBC3337-4^O:ECOLCB|1.1|ECOLCB^Escherichia coli - Carb||||||F|||201910291845
OBX|2|ST|800.5800^MDRO R^Multiresistant organism screen^^11502-2A^XBC3337-4^P:AMT|1.1|||||||F|||201910291845
OBX|3|ST|800.5800^MDRO R^Multiresistant organism screen^^11502-2A^XBC3337-4^R:4|1.1|4+||||||F|||201910291845
OBX|4|ST|800.5800^MDRO R^Multiresistant organism screen^^11502-2A^XBC3337-4|1.1|||||||F|||201910291845
NTE|1||Due to the resistance pattern of this {Escherichia coli -
NTE|2||Carb} patients may require contact precautions if they have
NTE|3||risk factors for transmission. Contact Infection Prevention
NTE|4||and Control for further information.
NTE|5||
NTE|6||A copy of these results has been sent to Infection
NTE|7||Prevention and Control.
NTE|8||
NTE|9||Isolate sent to BCCDC for further resistance typing.
NTE|10||
NTE|11||This {Escherichia coli} has a CARB carbapenemase gene.
NTE|12||Gene testing was confirmed/identified by BCCDC and/or the
NTE|13||National Microbiology Laboratory.
NTE|14||
NTE|15||Contact Infection Prevention and Control for further
NTE|16||information.
NTE|17||
NTE|18||A copy of these results has been sent to Infection
NTE|19||Prevention and Control.
OBR|2||00026590^19:X0000060R^MIC^19:X60^34604|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||201910290807|201910290803|||||||201910290803|Sputum^^^Expectorated|||||||||MB|F|11502-2A^1.1|||34604^MIC
OBX|1|ST|100.000^MER^Meropenem^^6652-2^6652-2|||||R|||F|||201910291845
OBX|2|ST|100.500^CAX^Ceftriaxone^^141-2^141-2|||||R|||F|||201910291845
OBX|3|ST|100.900^CFM^Cefixime^^80-2^80-2|||||R|||F|||201910291845
OBX|4|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||F|||201910291845
OBX|5|ST|101.100^CF^Cephalexin^^149-5^149-5|||||R|||F|||201910291845
OBX|6|ST|200.100^AM^Ampicillin^^28-1^28-1|||||R|||F|||201910291845
OBX|7|ST|300.100^TO^Tobramycin^^508-2^508-2|||||S|||F|||201910291845
OBX|8|ST|300.200^GM^Gentamicin^^267-5^267-5|||||R|||F|||201910291845
OBX|9|ST|500.650^CP^Ciprofloxacin^^185-9^185-9|||||R|||F|||201910291845
OBX|10|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||R|||F|||201910291845
OBX|11|ST|700.000^TE^Tetracycline^^496-0^496-0|||||S|||F|||201910291845

MSH|^~\&|MIC|ARH|||201910311159||ORU^R01|4094813|D|2.3|||AL|NE
PID|1||Pneumocystis|Pneumocystis|LABTESTHOUND^LUMED^||19600403|U||||||||||Pneumocystis/19|
OBR|1|34737^MIC|00026677^19:MT0000189R^MIC^19:MT189^34737|480.0900^PCP^Smear for Pneumocystis^^^XBC3175-4||201910311100|201910311056|||||||201910311056|Tracheal aspirate^^^|||||||||MB|I||||
OBX|1|CE|480.1010^PCP R^Smear for Pneumocystis^^48055-8^48055-8^O:PJIR|1.1|PJIR^Pneumocystis jirovecii seen||||||F|||201910311159

MSH|^~\&|MIC|ARH|||201910311200||ORU^R01|4094814|D|2.3|||AL|NE
PID|1||Pneumocystis|Pneumocystis|LABTESTHOUND^LUMED^||19600403|U||||||||||Pneumocystis/19|
OBR|1|34737^MIC|00026677^19:MT0000189R^MIC^19:MT189^34737|480.0900^PCP^Smear for Pneumocystis^^^XBC3175-4||201910311100|201910311056|||||||201910311056|Tracheal aspirate^^^|||||||||MB|F||||
OBX|1|CE|480.1010^PCP R^Smear for Pneumocystis^^48055-8^48055-8^O:PJIR|1.1|PJIR^Pneumocystis jirovecii seen||||||F|||201910311159
OBR|2|34737^MIC|00026677^19:MT0000189R^MIC^19:MT189^34737|480.1030^PJP PCR^PJP PCR^^^||201910311100|201910311056|||||||201910311056|Tracheal aspirate^^^|||||||||MB|F||||
OBX|1|CE|480.1035^PJPPCR R^PCR for Pneumocystis^^X50777^^O:PJIR|2.1|PJIR^Pneumocystis jirovecii seen||||||F|||201910311200

MSH|^~\&|MIC|ARH|||201910311157||ORU^R01|4094812|D|2.3|||AL|NE
PID|1||AB00008280|AB8186|LABTESTHOUND^LUMED^||19600403|U||||||||||AB000560/19|
OBR|1|34739^MIC|00026677^19:W0000571R^MIC^19:W571^34739|201.1000^FLB^Body fluid culture \T\ gram^^^611-4||201910311100|201910311056|||||||201910311056|Gastric aspirate^^^|||||||||MB|F||||
OBX|1|ST|100.0500^GSF^Gram stain^^664-3^664-3^P:GRAM|1|||||||F|||201910311157
OBX|2|ST|100.0500^GSF^Gram stain^^664-3^664-3^R:1 P|1|1+ Polymorphonuclear cells||||||F|||201910311157
OBX|3|ST|100.0500^GSF^Gram stain^^664-3^664-3^R:1 GNB|1|1+ Gram negative bacilli||||||F|||201910311157
OBX|4|CE|201.2000^FLBC^Body fluid culture^^6463-4^611-4^O:ECLO|2.1|ECLO^Enterobacter cloacae||||||F|||201910311157
OBX|5|ST|201.2000^FLBC^Body fluid culture^^6463-4^611-4^P:AMT|2.1|||||||F|||201910311157
OBX|6|ST|201.2000^FLBC^Body fluid culture^^6463-4^611-4^R:4|2.1|4+||||||F|||201910311157
OBR|2||00026677^19:W0000571R^MIC^19:W571^34739|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||201910311100|201910311056|||||||201910311056|Gastric aspirate^^^|||||||||MB|F|6463-4^2.1|||34739^MIC
OBX|1|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||R|||F|||201910311157
OBX|2|ST|200.100^AM^Ampicillin^^28-1^28-1|||||R|||F|||201910311157
OBX|3|ST|300.200^GM^Gentamicin^^267-5^267-5|||||S|||F|||201910311157
OBX|4|ST|500.650^CP^Ciprofloxacin^^185-9^185-9|||||S|||F|||201910311157
OBX|5|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||S|||F|||201910311157
OBX|6|ST|700.000^TE^Tetracycline^^496-0^496-0|||||S|||F|||201910311157

MSH|^~\&|MIC|ARH|||201910291753||ORU^R01|39849572|D|2.3|||AL|NE
PID|1||RC7420TwoMessages|RCTwoMessages|LABTEST^XRCCARDIAC^ONE||19450822|M||||||||||RCTwoMessages/18|PHNTwoMessages
OBR|1|OrmThenOru^MIC|00022992^19:OrmThenOru^MIC^19:U244^OrmThenOru|500.1000^U^Urine Culture^^^630-4||201910290807|201910290803|||||||201910290803|Urine^^^Midstream urine|||||||||MB|F||||
OBX|1|CE|500.1000^U^Urine Culture^^^630-4^O:EC0157|1.1|EC0157^Escherichia coli O157|||A|||P|||201910291319
OBX|2|ST|500.1000^U^Urine Culture^^^630-4^P:COLCOUNT10|1.1|||||||P|||201910291319
OBX|3|ST|500.1000^U^Urine Culture^^^630-4^R:10-99|1.1|1-9|x 10*6 CFU/L||A|||P|||201910291319

MSH|^~\&|MIC|SMH|||201911221427||ORU^R01|4111743|D|2.3|||AL|NE
PID|1||SM00046785|SM46576|LABTESTPOODLE^LUMED^||19501206|M||||||||||SM003264/19|9874955226
OBR|1|MicroOrderThenResult^MIC|00027235^19:MicroOrderThenResult^MIC^19:W629^MicroOrderThenResult|320.1010^WNDS^Wound (superficial)cult \T\ gram^^^17915-0||201911221338|201911220456|||||||201911221333|Abscess - perianal^^^|||||||||MB|I||||
OBX|1|ST|100.0110^GSW^Gram stain^^664-3^664-3^P:GRAM|1|||||||F|||201911221427
OBX|2|ST|100.0110^GSW^Gram stain^^664-3^664-3^R:2 GPC|1|2+ Gram positive cocci||||||F|||201911221427
OBX|3|CE|320.2010^WNSC^Wound superficial culture^^6463-4^17915-0^O:SAUR|2.1|SAUR^Staphylococcus aureus||||||P|||201911221427
OBX|4|ST|320.2010^WNSC^Wound superficial culture^^6463-4^17915-0^P:AMT|2.1|||||||P|||201911221427
OBX|5|ST|320.2010^WNSC^Wound superficial culture^^6463-4^17915-0^R:1|2.1|1+||||||P|||201911221427
OBX|6|ST|320.2010^WNSC^Wound superficial culture^^6463-4^17915-0^P:ORGIDSECOM|2.1|||||||P|||201911221427
OBX|7|ST|320.2010^WNSC^Wound superficial culture^^6463-4^17915-0^R:PREID|2.1|Preliminary identification - confirmation underway.||||||P|||201911221427
OBR|2||00027235^19:MicroOrderThenResult^MIC^19:W629^MicroOrderThenResult|913.2500^P580^Vitek P580 Sensitivity^^^29576-6||201911221338|201911220456|||||||201911221333|Abscess - perianal^^^|||||||||MB|P|6463-4^2.1|||MicroOrderThenResult^MIC
OBX|1|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||S|||P|||201911221427
OBX|2|ST|200.000^AUG^Amoxicillin/Clavulanate^^20-8^20-8|||||R|||P|||201911221427

MSH|^~\&|MIC|ARH|||201910291753||ORU^R01|398495722|D|2.3|||AL|NE
PID|1||MRChangeSampleDate|PIChangeSampleDate|LABTEST^XRCCARDIAC^ONE||19450822|M||||||||||RCChangeSampleDate/18|PHNChangeSampleDate
OBR|1|ChangeSampleDate^MIC|00022992^19:ChangeSampleDate^MIC^19:U244^ChangeSampleDate|500.1000^U^Urine Culture^^^630-4||201910290807|201910290803|||||||201910290803|Urine^^^Midstream urine|||||||||MB|F||||
OBX|1|CE|500.1000^U^Urine Culture^^^630-4^O:EC0157|1.1|EC0157^Escherichia coli O157|||A|||P|||201910291319

MSH|^~\&|MIC|ARH|||201910291753||ORU^R01|398495723|D|2.3|||AL|NE
PID|1||MRChangeSampleDate|PIChangeSampleDate|LABTEST^XRCCARDIAC^ONE||19450822|M||||||||||RCChangeSampleDate/18|PHNChangeSampleDate
OBR|1|ChangeSampleDate^MIC|00022992^19:ChangeSampleDate^MIC^19:U244^ChangeSampleDate|500.1000^U^Urine Culture^^^630-4||201910290807|201910290805|||||||201910290803|Urine^^^Midstream urine|||||||||MB|F||||
OBX|1|CE|500.1000^U^Urine Culture^^^630-4^O:EC0157|1.1|EC0157^Escherichia coli O157|||A|||P|||201910291319

MSH|^~\&|MIC|RMH|||202001221005||ORU^R01|4152007|D|2.3|||AL|NE
PID|1||RM00003594|RM3180|LABTESTTERRIER^LUMED^||19551001|F||||||||||RX000001/19|9874837888
OBR|1|38350^MIC|00028935^20:B0000009R^MIC^20:B9^38350|100.5005^BC^Blood culture^^^600-7||202001220958|202001200200|||||||202001200208|Blood^^^Peripheral|||||||||MB|I||||
OBX|1|ST|100.5010^BCT^Blood culture^^6463-4^600-7^S:NG48|1|No growth after 48 hours incubation.||||||P|||202001220959

MSH|^~\&|MIC|RMH|||202001221006||ORU^R01|4152021|D|2.3|||AL|NE
PID|1||RM00003594|RM3180|LABTESTTERRIER^LUMED^||19551001|F||||||||||RX000001/19|9874837888
OBR|1|38350^MIC|00028935^20:B0000009R^MIC^20:B9^38350|100.5005^BC^Blood culture^^^600-7||202001220958|202001200200|||||||202001200208|Blood^^^Peripheral|||||||||MB|D||||
OBX|1|ST|100.5010^BCT^Blood culture^^6463-4^600-7^S:NG48|1|No growth after 48 hours incubation.||||||D|||202001220959